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ABSTRACT 
Objective: To estimate the incidence and causes of visual impairment for the 
purposes of service provision, among the indigenous Australian population within 
central Australia from its most common causes, namely cataract, diabetic retinopathy 
and trachoma. 
Design: Clinic-based cohort study. 
Participants: 1,884 individuals aged ≥20 years living in one of 30 remote 
communities within the statistical local area of ‘Central Australia’.  
Methods: From those initially recruited, 608 (32%) participants were reviewed again 
between 6 months and 3 years (median 2 years). Patients underwent snellen visual 
acuity testing and subjective refraction. Following this, an assessment of their anterior 
and posterior segments was made. Baseline results were compared with those who 
were reviewed.  
Main Outcome Measures: The annual incidence rates and causes of visual 
impairment (vision worse than Snellen visual acuity 6/12 in at least one eye). 
Results: The incidence of visual impairment in at least one eye was 6.6%, 1.2% and 
0.7% per year for cataract, diabetic retinopathy and trachoma respectively (7.9%, 
1.5% and 0.7% per year for those aged ≥40 years). Advancing age was the main risk 
factor common to all three. 
Conclusion: It is important to be mindful not only of the prevalence of disease in a 
community, but also of the rate at which new cases are occurring when allocating 
resources to address the ocular health needs of this region. Compared with historical 
data diabetic retinopathy is emerging as a new and increasing threat to vision in this 
population.
Vision loss reduces ability of individuals to function independently.
1
 In Australia, 
when Snellen visual acuity is reduced to worse than 6/12, a person may not be eligible 
to hold a drivers licence.
2
 However, visual impairment may also have consequences 
for a person’s ability to earn an income,1 and has been found to impact significantly 
on quality of life to a similar degree as a major medical condition such as stroke.
3
 
This outcome association has been found in a number of studies
4,5
 including those 
which assessed indigenous populations in other parts of the world.
6
  
 Central Australia is an area with a unique population requiring targeted service 
provision. There are distinct barriers to access found in few other places in Australia, 
which must be overcome before issues related to health and well-being may be 
addressed. Although patients may be assessed in the remote communities, much of the 
service provision must be delivered centrally at Alice Springs Hospital. There exist 
substantial logistic challenges in relation to conveying patients to the service centre 
and dispensing health services in a manner which is culturally acceptable. However, 
as ophthalmic care is one service among many, it has often been de-emphasized and 
as a result, the delivery of services has not kept pace with the requirements of the 
region. For many years a paucity of accurate data prevented informed service 
planning. 
Within the indigenous population of remote central Australia, bilateral visual 
impairment occurs in over 25% of those aged 40 year or older (a prevalence almost 4 
times that of the non-indigenous population).
7
 The most common causes for this after 
refractive error were cataract, diabetic retinopathy and trachoma.
7
 In order to develop 
effective strategies to address the underlying causes of visual impairment it is 
important to understand not only the prevalence, but also the rate at which it is 
continuing to occur. Bilateral visual impairment places legal restrictions on an 
individual’s abilities; however consideration of unilateral visual impairment is 
important as it enumerates the total number in need of ophthalmic intervention. 
The Central Australian Ocular Health Study has been designed to estimate the 
prevalence of ocular morbidity among the indigenous Australian population living in 
remote central Australia. The study ran over 3 years, and as such, a proportion of the 
participants were examined on more than one occasion. This allowed an estimation of 
the incidence of ocular morbidity to be determined. The purpose of this paper was to 
determine the incidence of the most common causes of visual impairment in at least 
one eye among indigenous Australians living in central Australia. 
 
METHODS 
 
The Central Australian Ocular Health Study took place in the 30 largest 
remote communities within the statistical local area of ‘Central Australia’, excluding 
those living within and around the city of Alice Springs (target population of 5,173 
persons aged ≥20 years)(Figure). Ethical approval from the Central Australian Human 
Research Ethics Committee was obtained and conformed to the tenets of the 
Declaration of Helsinki.  
A total of 1884 individuals who identified themselves as indigenous 
Australians, were recruited between July 2005 and June 2008 as they presented to the 
remote clinics at each of these communities. The aims of the study were explained, 
with an interpreter whenever necessary and written informed consent was obtained. 
Routine review appointments were then made for every patient between 6 and 12 
months later, depending on when the next remote clinic visit was scheduled. Their 
baseline data provided prevalence estimates of ocular morbidity for this population. 
During the following 36 month time period, a proportion was reviewed more than 
once. Those who were reviewed between 6 months and 3 years after their baseline 
examination, were compared with their baseline data in order to determine the 
incidence of ocular morbidity within this region.  
Best corrected visual acuity (BCVA) following refractive correction was 
determined using a tumbling E acuity chart at 3 metres in a well-lit room. If the 
patient could not read the top letter (6/120 equivalent), they were recorded as either 
counting fingers at 2 metres or 1 metre, hand movements, light perception or no light 
perception. A slit-lamp examination of the anterior segment was performed and 
grading of trachomatous corneal opacification was performed using the WHO 
simplified grading system.
8
 Pupils were then dilated with tropicamide 1.0% and 
phenylephrine 2.5% and lens grading was performed using the modified Lens 
Opacities Classification System III.
9
 Slit-lamp fundoscopy was performed using a 
90D fundoscopy lens. This included a clinical assessment of the posterior pole and the 
peripheral retina to estimate the presence and degree of diabetic retinopathy using the 
Early Treatment of Diabetic Retinopathy Study adaptation of the modified Airlie 
House classification of diabetic retinopathy.
10 
Visual impairment in an eye was defined as a BCVA of less than 6/12. If an 
eye was found to have acuity at this level, then the examining ophthalmologist made 
an assessment regarding the major cause of visual impairment in each eye. These 
review data were then compared with those obtained at baseline among groups who 
had a BCVA of 6/12 or better in either eye in order to establish the incidence of visual 
impairment in one or both eyes from cataract, diabetic retinopathy or trachoma. If a 
patient presented to the clinics more than twice during the recruitment period, the 
entry recorded was the first time point at which the patient was found to meet the 
definition threshold of worse than 6/12. If this was not found at any time point, the 
entry recorded was the last time that they were seen. The annual incidence rate was 
calculated from the incidence density rate, whereby the total number of years for 
which each patient was followed, was divided into the number of incident cases that 
developed during these person-years. The resultant rate per person-years was then 
converted into a rate per year. 
Statistical Analysis System 9.1 (SAS Institute Inc, Cary, NC) was used for 
statistical analysis including descriptive statistics, student t-test, chi-squared test and 
cox proportional hazards model. Age was considered as a continuous variable. Sex, 
visual impairment, blindness, diabetes and hypertension were considered as 
categorical variables. Test statistics, 95% confidence intervals and p values are 
presented. A p value of <0.05 was considered statistically significant. 
 
RESULTS 
 
The original sample contained 1884 participants, which included 689 (36.6%) 
males and 1195 (63.4%) females, the average age of which were 49 years (SD 15yrs; 
range: 20 to 93 years). Of these, 1040 had self-reported diabetes. From this original 
sample, 366 were excluded, either because they could not be assessed due to media 
opacity, or because their visual acuity was worse than 6/12 in both eyes.  Of the 
remaining 1518 who were assessable and had a visual acuity of 6/12 or better in one 
or both eyes, 1011 were diabetic.  
608 of the original sample of 1884 participants (32%) were reviewed between 
6 months and 3 years (median 2 years) after their initial assessment. Compared with 
the original sample, the group which was reviewed contained a higher proportion of 
females, (203 of these were male (33.4%) and 405 females (66.6%), 2=3.95; 
P=0.047), and was older (53 years (SD 14yrs), t=5.81; P<0.0001). 461 (of the original 
1518) were assessable and had a visual acuity of 6/12 or better in one or both eyes at 
baseline, 335 of whom were diabetic. 
 
Cataract 
 
During the follow-up period, 51 participants were found to have developed 
visual impairment in one or both eyes due to cataract. This equated to an annual 
incidence in the sample of 6.63% (95% C.I 4.36 to 8.90%), and for those aged ≥40 
years of 7.85%; (95% C.I 5.06 to 10.64%) per year. As expected, advancing age was 
found to be associated with the development of visual impairment due to cataract, 
with the risk increasing by 20% with each decade of life  (Hazard ratio=1.2, 95% C.I 
1.1-1.3; P<0.0001). Sex, diabetes and hypertension were not found to be associated 
with incident cataract. 
 
Diabetes 
 
9 participants with diabetes were found to have developed visual impairment 
in one or both eyes due to diabetic retinopathy. This equates to an incidence of 1.24% 
in the whole sample (95% C.I 0.05 to 2.43%), and 1.53% (95% C.I 0.04 to 3.08%) in 
those aged ≥40 years per year. Those who developed visual impairment due to 
diabetes were older (56 years versus 49 years, t=2.35; P=0.047), however this was no 
longer significant after adjustment for sex and hypertension.  
 
Trachoma 
5 participants developed visual impairment in one or both eyes due to 
trachoma during the follow-up period, equating to an annual incidence of 0.65% in 
the whole sample (95% C.I 0.00 to 1.38%), and 0.84% for those aged ≥40 years (95% 
C.I 0.00 to 1.79%) per year. These participants were older (62 years versus 49 years, 
t=2.33; P=0.08) and were all female. None of the individuals who developed 
trachoma had hypertension and 2/335 (0.6%) had diabetes versus 3/123 (2.4%) 
without (2=2.36; P=0.13). Numbers were too small to do an adjusted analysis. 
 
DISCUSSION 
 
Developing visual impairment has significant implications to the individual, 
relating to loss of drivers licence
2
 and employment,
1
 loss of independence
1
 and self-
esteem.
4,5
 Poorer self-rated quality of life measures have been consistently found 
among those with unilateral
11
 and bilateral visual impairment.
3
 We have found that 
for those aged 40 years or older, visual impairment occurred in at least one eye at 
rates of 7.9% per year, 1.5% per year and 0.7% per year due to cataract, diabetic 
retinopathy and trachoma respectively.  
 Cataract is the most common, non-refractive cause of incident visual 
impairment in Australia.
7,12,13
 We have found previously that 17% of indigenous 
Australians aged 40 years or older are visually impaired in one or both eyes from 
cataract.
14
 We have now shown that this figure increases by 7.9% each year. If this 
were applied to the whole population living in remote central Australia, 
approximately 120 extra patients per year (or 10 patients per month) potentially 
requiring cataract surgery would be added to the 350 already present in the 
population.
14
 During the time period in which the data was collected, resources 
allocated to providing cataract services to central Australia allowed for only 120 
cataract procedures to be performed per year. Therefore, based on our estimate of 
incidence, at the rate which cataract surgery was being performed, there would have 
been no changes in the underlying prevalence in the community. Although, since then 
service provision has doubled; at the same time, in recent years the rate at which 
patients are being booked has continued to be twice the rate at which operations are 
being performed. Therefore, although the current rate of cataract procedures may have 
exceeded the incidence of cataract development, increased case finding has ensured 
no change in the cataract waiting list.  
 Diabetes is a highly prevalent disease among indigenous Australians, affecting 
over 40% of the population
15
 and possibly more than 50% given that the prevalence 
has not been estimated in over 10 years. Within remote central Australia diabetic 
retinopathy is now the most common cause of non-refractive visual impairment after 
cataract.
7
 If our estimates of incident visual impairment were applied to this 
population, it would mean that 34 patients each year (or 3 patients per month) would 
become visually impaired from diabetes. This figure is of a similar magnitude to that 
quoted in other studies of Caucasian populations.
16,17
 Given that each patient may 
require ongoing treatments including laser, intravitreal injections and/or surgery, 
service delivery should be planned accordingly or else treatment delays may result in 
irreversible blindness.  
Within Australia, trachoma is only prevalent among the indigenous 
community and is the most common cause of non-refractive blindness after cataract.
7
 
Our incidence estimate of 0.7% per year for the entire sample (31 new patients per 
year) is in the same order of magnitude as that found in other countries where 
trachoma is endemic.
18
 There was a trend towards an association with gender and age, 
which have been demonstrated before in previous work.
18,19 
 Our study was limited by the method in which participants with vision loss 
were identified. Recruitment and follow-up required voluntary presentation to one of 
the remote clinics. Therefore, presentation may have been motivated by symptoms 
relating to vision loss, increasing our estimates of incident vision impairment. 
However, each patient had a routine review appointment made between 6 and 12 
months, depending on when the next remote clinic visit was scheduled. As has been 
mentioned before, the clinics only occurred once or twice per year at each remote 
community, therefore the health workers in the communities would actively 
encourage every resident to attend the clinics regardless of their symptoms. In fact, 
95% of those originally recruited, presented to the clinic for a “check-up” and not due 
to symptoms.
20
 This was also the case for those who were followed up. Participants 
who were originally recruited were more likely to be female, a trend which was also 
found in our follow-up group. Males are less likely to present to a health 
professional,
21
 a phenomenon which has been observed in previous work involving 
non-indigenous populations
22
 and there is evidence that this may translate over to the 
indigenous Australian population.
23,24
 Compared with our target population, our 
original sample was older than the target population.
20
 We collected data on 36% of 
the population within the central Australian statistical subdivision who were aged 20 
years or older and this recruitment increased with age, such that 67% of those aged 40 
years or older and 75% of those age 50 years or older were included.
20
 However, as a 
result, the original recruitment sample became more representative of the target 
population from remote central Australia with advancing age, as younger people were 
less likely to present to the remote clinics. In a similar way, our follow-up sample was 
older than those originally recruited. However, given that most comparisons being 
made with non-indigenous Australian groups are among those aged 40 years or 
older,
12,13
 we feel that the over-representation of older participants in our follow-up 
sample should ensure that our data closely reflects the true incidence among the older 
members of  our target population. Participants were followed up gradually over a 
period of between 6 months to 3 years and it is possible that a participant reviewed 
early in the follow-up period may have developed vision loss later in the follow-up 
period, but this would not have been recorded. This would be an unavoidable 
consequence of our method of data entry. Furthermore, although the possibility exists 
that our estimates may have been affected by selection bias, given that 95% of 
presentations occurred independent of symptoms,  we are confident that our results 
represent the best available estimate of the incidence of vision loss in this population. 
 This study has estimated the annual incidence of visual impairment among the 
indigenous Australian population within central Australia in at least one eye from its 
most common causes, namely cataract, diabetic retinopathy and trachoma. It is 
important to mindful of this information when allocating resources to address the 
future ocular health needs of this region. This is particularly important when 
considering increases in the prevalence of diabetes, but also increases in health 
standards and life expectancy; all of which will enhance the demand for appropriate 
and accessible ocular health services.  
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Schematic map of the central Australian statistical local area. (▲) Communities  
 
visited during the study. 
 
 
